gamechanger testThe Company expects its saliva-based COVID-19 antigen test to become the first rapid test to receive FDA-EUA approval. As AcuVid™ is an innovative, leading-edge rapid saliva test solution, additional information was required for the FDA-EUA review process. just waiting for pawsi signature